C9orf72 and amyotrophic lateral sclerosis: It will be necessary to compare (through multi‐centre collaboration) an asymptomatic group with a larger group of both symptomatic ALS and symptomatic FTD C9orf72 expansion heterozygotes, which might also help to untangle the contribution of any neurodevelopmental differences associated with this genotype.